Alec Machiels, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 6,000 shares at $43.50 ($236K) on 2021-11-15, disclosed to the SEC on 2021-11-17.
Open-market sale of $236k APLS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 3,000 | $105K | 44.6% |
| 2 | $43.50 | 3,000 | $131K | 55.4% |
| Total | $39.25 avg | 6,000 | $236K | 100% |
| Filing → |
| APLS | SELL | 2023-09-19 | $56K | — | Filing → |
| APLS | SELL | 2023-09-18 | $113K | — | Filing → |
| APLS | SELL | 2023-07-18 | $162K | — | Filing → |